Portfolio News
- February 08, 2010 Anthera Pharmaceuticals Announces Agreement with the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
- January 27, 2010 Movetis launches Resolor® in Germany
- January 21, 2010 Laszlo Systems Secures $3M Financing from MMV Financial
- January 13, 2010 - BioWorld TodayStructural Study of PI3 Kinase Suggests Targeting Strategies
- January 12, 2010 3D Structure of Key Drug Target Sheds Light on How to Design Better Drugs
Contact
Contact information for our offices in Menlo Park, San Francisco, and San Diego.
For information about our sister firm Sofinnova Partners based in Paris, France, please visit www.sofinnova.fr.
